ORTEXORTEX News
Tracking MPLX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
MP
Earnings PreviewMPLX

MPLX Options Traders Turn Defensive Before Tuesday's Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 24 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of MPLX LP (MPLX) share price and short interest (% of free float), three months to October 22, 2026
ORTEX data as of 24 Oct 2026, 04:02

Options positioning on MPLX has shifted more cautious than at any point in recent months, even as short sellers hold steady and the borrow market remains loose. The put/call ratio jumped to 0.56 on October 23, more than two standard deviations above its 20-day average of 0.42. That is the most defensive reading in months, approaching but not yet at the 52-week high of 0.70. The stock itself added 1.6% on Friday to close at $59.13, up 1.7% on the week, though that trailed the median weekly gain of 2.7% across its closest midstream peers.

The options signal stands in contrast to the short-selling picture, which tells a much quieter story. Short interest is only 0.66% of the free float, down around 7% over the month as roughly half a million shares were covered since late September. Borrow costs are negligible at 0.31%, and availability is exceptionally wide at 1,596%, meaning there are roughly 16 shares available to lend for every one already shorted. There is no meaningful squeeze pressure and no sign that short sellers are building a significant position into the result.

The debate around MPLX centres on whether project completions translate into EBITDA growth or whether commodity and margin softness offsets the ramp. The bull case rests on fee-based cash flow durability: the Marcellus and Permian footprint provides volume visibility, new projects including Harmon Creek III and Blackcomb are commissioning through the second half of 2026, and a roughly 7% distribution yield with double-digit planned increases in 2026 and 2027 anchors the income argument. The bear case focuses on processing margin sensitivity, NGL price exposure, and the risk that commissioning delays in LNG and ethylene cracking keep supply-demand loose longer than modelled. Two bellwether moves in the past two weeks reflect the split: JP Morgan assumed coverage at Neutral with a $62 target on October 20, and Morgan Stanley trimmed its target from $66 to $64 while holding Equal-Weight on October 13. The consensus mean sits at $62.69, roughly 6% above the current price, but the direction of recent revisions is cautious rather than optimistic.

Among closely correlated peers, EPD and KMI each gained roughly 2.7% on the week, OKE added 3.6%, and DTM rose nearly 4%. MPLX's 1.7% weekly gain lagged the group. The pattern is consistent with the stock's income-oriented investor base, which tends to keep price action anchored near the distribution yield rather than chasing momentum. Marathon Petroleum holds 63.9% of units, a structural fact that caps free-float volatility and keeps the lending market well-supplied regardless of sentiment shifts. Past earnings reactions have been muted: the August 2026 print produced a one-day move of less than 1% and a five-day move of similar size.

Tuesday's result will test whether the project commissioning timeline remains on track and whether EBITDA for Q3 can sustain the trajectory that justified the distribution growth guidance.

Against its peers

Shares moved +1.7% over the past week against a median of +2.7% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open MPLX on ORTEX →

How this article was generated

Generated
24 Oct 2026, 04:20
Data as of
24 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.